| Group Results | Key Products | Product Therapies |
|---|---|---|
|
What is 34B GBP? (26% Cx, 21% Vx, 52% Rx--> 4% like for like overall)
Overall group revenue was: a) 18B GBP, b) 26B GBP, c) 34B GBP or d) 50B GBP?
|
What are Advair and Ventolin?
Name two brands that went generic in 2019.
|
What is Flu (Flularix + Flulaval)?
Name the most seasonal vaccine product.
|
|
What is Future Ready?
Name the new name for the project to separate the Pharma and Consumer business.
|
What is Trelegy, Nucala, Shingrix, Bexsero, Ventolin?
Name the two of the top 5 brands driving growth in 2019.
|
What is Menveo or Bexsero?
Name a meningitis product.
|
|
What is product launch advertising, Advair generic impact, or R&D investment?
Name a reason why costs were up YoY.
|
What is Zejula (Oncology) or Dovato (Viiv)?
Name either the Viiv or the Oncology product launched in 2019.
|
What is Dovato, Juluca, Triumeq, Tivicay or other?
Name two Viiv products.
|
Support Us on Ko-fi